Actualités
Integrating NCDs into National Health Plans: Smarter Financing and Buying Strategies
Over the past two decades, noncommunicable diseases (NCDs) and mental health have evolved from niche concerns in global health to central pillars of the sustainable development agenda. Since the 2011 High-level Meeting on the Prevention and Control of NCDs,...
IDA Foundation and FIND work together to improve access to tests for non-communicable diseases
IDA Foundation and FIND have joined forces to help address the challenges of availability, affordability, and optimal use of diagnostics for non-communicable diseases (NCDs) in low- and middle-income countries (LMICs). Buyers in LMICs will be able to procure...
IDA Foundation and the Coalition for Access to NCD Medicines & Products Forge a Partnership to Combat Global Non-Communicable Disease Challenges
In a significant stride towards addressing the global challenge of Non-Communicable Diseases (NCDs), IDA Foundation and the Coalition for Access to NCD Medicines & Products are proud to announce their partnership. NCDs, encompassing chronic conditions such as...
Meet the NCDconnect Team!
Have you heard about NCDconnect? Through the innovative NCDconnect platform, IDA Foundation and Solvoz have formed a strategic partnership, united in their mission to streamline the procurement of high-quality NCD medicines, medical supplies, and diagnostics. Serving...
IDA Foundation and ATOM Coalition Join Forces to Bridge Gaps in Cancer Treatment Access through NCDconnect
IDA Foundation and the Access to Oncology Medicines (ATOM) Coalition are happy to announce their strategic partnership. Following World Cancer Day’s theme ‘Close the Care Gap’, this collaboration marks a significant step toward addressing the challenges of...
Global Perspectives on Cervical Cancer: Achieving Targets, Overcoming Challenges, and Fostering Collaborations
The global impact of cervical cancer is staggering, with approximately 604,000 new cases recorded in 2020, resulting in 342,000 deaths – 90% of which occurred in low- and middle-income countries (LMICs) (Source: WHO). Estimated age-standardized incidence rates (World)...
Combating the Scourge of Substandard Medicines in Low and Middle-Income Countries: IDA Foundation’s Commitment to Quality Assurance
Credit: Tom van der Leij-pharmacy Counterfeit and substandard medicine trafficking is one of the world’s fastest-growing and highest-value criminal enterprises. Analysts estimate the global counterfeit market to be worth between US$200 and $432 billion. Since the...
NCDconnect: Accelerating towards Universal Health Coverage in LMICs
Non-communicable diseases (NCDs) present a global health crisis, exacerbated by the COVID-19 pandemic. These diseases, including cancer, cardiovascular disease, hypertension, diabetes, and chronic respiratory illnesses, claim a staggering 41 million lives every year....